Skip to main content

15 years young man from south of China attempted 1'000 jumps just for 2 minutes and 47 seconds


The wondeful dance that young chineese perfom.    Remember the famous dialogue from Sholay where Gabbar Singh says “Bahut nainsafi hain…goli ek aur aadmi teen”? 

Yes, not in terms of bullets, but certainly it is not fair to pitch five against one. 
But certainly this difficult situation was nothing to Cen Xiaolin, a 15-year-old high-school student from Guangzhou, south China’s Guangdong Province.

Xiaolin completed an “impossible challenge”, jumping faster than a team of national rope-jumping champions.
He alone against a five-person relay team left the audience mesmerised with a jaw-dropping performance as he attempted 1,000 jumps at lightning speed.

just 2 minute 47 seconds, Xiaolin reached his target – having stopped only once when the rope was caught between his shoes at 966. 

With elfin 34 jumps short of his victory feat, the audience and judges cheered him and encouraged him to reach his goal ahead of the entire team. 

His energy and zeal was so captivating that the entire audience left breathless just by looking at him. 
And so would anyone looking at this video.While the 1,000 jumps were equally divided among the five players, Xiaolin was always ahead of them by at least 10 jumps. Only the third player almost caught up, but the player’s shoe too was caught in between the rope and the margin increased once gain.

The high power challenge was conducted in popular Chinese reality show called – ‘Beyond the Edge’, broadcast by the China Central Television. 
The popular TV show is known for showing extraordinary stunts and challenges by common people. In the second season, for the first episode participants tried to break many Guinness World Record on the show

Comments

Popular posts from this blog

Philippines make the most its English ability

MANILA -- Amid central Manila's construction boom, a redevelopment project by Ayala Land is especially eye-catching. The project includes a 69-story building and a condominium whose apartments go for an average 80 million pesos ($1.65 million). That is almost on a par with prices in Tokyo, yet the real estate developer said it received a flood of inquiries when the apartments went on sale in June. Investors are buying the company's shares in expectation of higher revenues. The share price rose about 14% from the start of the year to the end of September. The Ayala project highlights the rising income levels in the Philippines. Taking advantage of its large English-speaking population, the country has become one of the biggest providers of business process outsourcing services. Surging employment in this sector has created a consumption boom among the growing middle class. Robinsons Retail Holdings, which operates convenience store and supermarket chains, saw its sales rise 6...

Tanzani When the earthquake struck, the brick walls simply crumbled at the orphanage in Tanzania

  Tanzani When the earthquake struck, the brick walls simply crumbled at the orphanage in Tanzania's far northwestern Kagera region.Clutching one of the youngest children, Saada Suleiman said she tried to run as Saturday's tremormade the ground heave beneath her feet."I felt something, as though someone was pushing me from behind, and suddenly the building was shaking," said Suleiman, who operates the Uyacho Orphanage Centre in Bukoba township. 

HIV treatment is ready for trials

Live news Uploaded at 15:41 5 September 2023 Getty Images Copyright: Getty Images Anti-retroviral therapy trials are expected to begin in Denmark before the end of the year, with a drug that could prove to be a long-awaited cure for the AIDS virus. The results of preliminary laboratory tests carried out by two teams of Australian scientists in collaboration with their colleagues from Denmark are encouraging about the hope of finding a cure. An Australian study clearly shows that the Oncologic drug venetoclax has the ability to detect "cells" in the human body that are adversely affected by the virus. Next year, in addition to Denmark, trials of the drug will also begin in Melbourne, Australia. Meanwhile, pills with the trade name VENCLEXTA were originally developed to fight blood cancer. It was approved in the United States in 2016 and since then, according to doctors, it has already helped thousands of cancer patients. There are currently around 40 million people living with...